Interleukin-6 inhibits hepatic growth hormone signaling via upregulation of Cis and Socs-3

American Journal of Physiology - Gastrointestinal and Liver Physiology

Volumn 284, Issue 4 47-4, 2003, Pages

  Denson, Lee A ^a   Held, Matthew A ^a   Menon, Ram K ^b   Frank, Stuart J ^c   Parlow, Albert F ^d   Arnold, Dodie L ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b CHILDREN S HOSPITAL OF PITTSBURGH   (United States)

^c University of Alabama at Birmingham   (United States)

^d HARBOR UCLA MEDICAL CENTER   (United States)

Author keywords

Cytokines; Endotoxin; STAT3; STAT5; Suppressors of cytokine signaling

Indexed keywords

CYTOKINE INDUCIBLE SH2 CONTAINING PROTEIN 1; GROWTH FACTOR; GROWTH HORMONE RECEPTOR; HEPATIC GROWTH HORMONE; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; PROTEIN INHIBITOR; STAT3 PROTEIN; STAT5 PROTEIN; SUPPRESSOR OF CYTOKINE SIGNALING 1; SUPPRESSOR OF CYTOKINE SIGNALING 2; SUPPRESSOR OF CYTOKINE SIGNALING 3; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR 1; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOACCUMULATION; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; GEL MOBILITY SHIFT ASSAY; GENE CONTROL; GENE EXPRESSION REGULATION; HORMONE ACTION; HORMONE RESISTANCE; IMMUNOBLOTTING; INFLAMMATORY DISEASE; MALE; MOUSE; MOUSE STRAIN; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN INDUCTION; PROTEIN PHOSPHORYLATION; REGULATORY MECHANISM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; UPREGULATION;

EID: 0037378320     PISSN: 01931857     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpgi.00178.2002     Document Type: Article

References (38)

1. Auernhammer CJ, Bousquet C, and Melmed S. Autoregulation of pituitary corticotroph SOCS-3 expression: characterization of the murine SOCS-3 promoter. Proc Natl Acad Sci USA 96: 6964-6969, 1999.
2. Ballinger AB, Azooz O, El-Haj T, Poole S, and Farthing MJ. Growth failure occurs through a decrease in insulin-like growth factor 1 which is independent of undernutrition in a rat model of colitis. Gut 46: 694-700, 2000.
3. Ballinger AB, Camacho-Hubner C, and Croft NM. Growth failure and intestinal inflammation. QJM 94: 121-125, 2001.
4. Bergad PL, Schwarzenberg SJ, Humbert JT, Morrison M, Amarasinghe S, Towle HC, and Berry SA. Inhibition of growth hormone action in models of inflammation. Am J Physiol Cell Physiol 279: C1906-C1917, 2000.
5. Boisclair YR, Wang J, Shi J, Hurst KR, and Ooi GT. Role of the suppressor of cytokine signaling-3 in mediating the inhibitory effects of interleukin-lbeta on the growth hormone-dependent transcription of the acid-labile subunit gene in liver cells. J Biol Chem 275: 3841-3847, 2000.
6. Campbell JS, Prichard L, Schaper F, Schmitz J, Stephenson-Famy A, Rosenfeld ME, Argast GM, Heinrich PC, and Fausto N. Expression of suppressors of cytokine signaling during liver regeneration. J Clin Invest 107: 1285-1292, 2001.
7. Cohney SJ, Sanden D, Cacalano NA, Yoshimura A, Mui A, Migone TS, and Johnston JA. SOCS-3 is tyrosine phosphorylated in response to interleukin-2 and suppresses STAT5 phosphorylation and lymphocyte proliferation. Mol Cell Biol 19: 4980-4988, 1999.
8. Colson A, Le Cam A, Maiter D, Edery M, and Thissen JP. Potentiation of growth hormone-induced liver suppressors of cytokine signaling messenger ribonucleic acid by cytokines. Endocrinology 141: 3687-3695, 2000.
9. Davey HW, Park SH, Grattan DR, McLachlan MJ, and Waxman DJ. STAT5b-deficient mice are growth hormone pulseresistant. Role of STAT5b in sex-specific liver p450 expression. J Biol Chem 274: 35331-35336, 1999.
10. Davey HW, Xie T, McLachlan MJ, Wilkins RJ, Waxman DJ, and Grattan DR. STAT5b is required for GH-induced liver IGF-I gene expression. Endocrinology 142: 3836-3841, 2001.
11. De Benedetti F, Alonzi T, Moretta A, Lazzaro D, Costa P, Poli V, Martini A, Ciliberto G, and Fattori E. Interleukin 6 causes growth impairment in transgenic mice through a decrease in insulin-like growth factor-I. A model for stunted growth in children with chronic inflammation. J Clin Invest 99: 643-650, 1997.
12. Defalque D, Brandt N, Ketelslegers JM, and Thissen JP. GH insensitivity induced by endotoxin injection is associated with decreased liver GH receptors. Am J Physiol Endocrinol Metab 276: E565-E572, 1999.
13. Denson LA, Menon RK, Shaufl A, Bajwa HS, Williams CR, and Karpen SJ. TNF-α downregulates murine hepatic growth hormone receptor expression by inhibiting Sp1 and Sp3 binding. J Clin Invest 107: 1451-1458, 2001.
14. Douni E, Akassoglou K, Alexopoulou L, Georgopoulos S, Haralambous S, Hill S, Kassiotis G, Kontoyiannis D, Pasparakis M, Plows D, Probert L, and Kollias G. Transgenic and knockout analyses of the role of TNF in immune regulation and disease pathogenesis. J Inflamm 47: 27-38, 1995.
15. Fantuzzi G and Dinarello CA. The inflammatory response in interleukin-1 beta-deficient mice: comparison with other cytokine-related knock-out mice. J Leukoc Biol 59: 489-493, 1996.
16. Fantuzzi G, Zheng H, Faggioni R, Benigni F, Ghezzi P, Sipe JD, Shaw AR, and Dinarello CA. Effect of endotoxin in IL-1 beta-deficient mice. J Immunol 157: 291-296, 1996.
17. Fattori E, Cappelletti M, Costa P, Sellitto C, Cantoni L, Carelli M, Faggioni R, Fantuzzi G, Ghezzi P, and Poli V. Defective inflammatory response in interleukin 6-deficient mice. J Exp Med 180: 1243-1250, 1994.
18. Gregorieff A, Pyronnet S, Sonenberg N, and Veillette A. Regulation of SOCS-1 expression by translational repression. J Biol Chem 275: 21596-21604, 2000.
19. He X, Goldsmith CM, Marmary Y, Wellner RB, Parlow AF, Nieman LK, and Baum BJ. Systemic action of human growth hormone following adenovirus-mediated gene transfer to rat submandibular glands. Gene Ther 5: 537-541, 1998.
20. Kontoyiannis D, Pasparakis M, Pizarro TT, Cominelli F, and Kollias G. Impaired on/off regulation of TNF biosynthesis in mice lacking TNF AU-rich elements: implications for joint and gut-associated immunopathologies. Immunity 10: 387-398, 1999.
21. Krebs DL and Hilton DJ. SOCS: physiological suppressors of cytokine signaling. J Cell Sci 113: 2813-2819, 2000.
22. Mao Y, Ling PR, Fitzgibbons TP, McCowen KC, Frick GP, Bistrian BR, and Smith RJ. Endotoxin-induced inhibition of growth hormone receptor signaling in rat liver in vivo. Endocrinology 140: 5505-5515, 1999.
23. Matsumoto A, Masuhara M, Mitsui K, Yokouchi M, Ohtsubo M, Misawa H, Miyajima A, and Yoshimura A. CIS, a cytokine inducible SH2 protein, is a target of the JAK-STAT5 pathway and modulates STAT5 activation. Blood 89: 3148-3154, 1997.
24. Matsumoto A, Seki Y, Kubo M, Ohtsuka S, Suzuki A, Hayashi I, Tsuji K, Nakahata T, Okabe M, Yamada S, and Yoshimura A. Suppression of STAT5 functions in liver, mammary glands, and T cells in cytokine-inducible SH2-containing protein 1 transgenic mice. Mol Cell Biol 19: 6396-6407, 1999.
25. Metcalf D, Greenhalgh CJ, Viney E, Willson TA, Starr R, Nicola NA, Hilton DJ, and Alexander WS. Gigantism in mice lacking suppressor of cytokine signalling-2. Nature 405: 1069-1073, 2000.
26. Paul C, Seiliez I, Thissen JP, and Le Cam A. Regulation of expression of the rat SOCS-3 gene in hepatocytes by growth hormone, interleukin-6 and glucocorticoids mRNA analysis and promoter characterization. Eur J Biochem 267: 5849-5857, 2000.
27. Ram PA and Waxman DJ. SOCS/CIS protein inhibition of growth hormone-stimulated STAT5 signaling by multiple mechanisms. J Biol Chem 274: 35553-35561, 1999.
28. Ram PA and Waxman DJ. Role of the cytokine-inducible SH2 protein CIS in desensitization of STAT5b signaling by continuous growth hormone. J Biol Chem 275: 39487-39496, 2000.
29. Rothe J, Lesslauer W, Lotscher H, Lang Y, Koebel P, Kontgen F, Althage A, Zinkernagel R, Steinmetz M, and Bluethmann H. Mice lacking the tumour necrosis factor receptor 1 are resistant to TNF-mediated toxicity but highly susceptible to infection by Listeria monocytogenes. Nature 364: 798-802, 1993.
30. Schaefer F, Chen Y, Tsao T, Nouri P, and Rabkin R. Impaired JAK-STAT signal transduction contributes to growth hormone resistance in chronic uremia. J Clin Invest 108: 467-475, 2001.
31. Starr R, Metcalf D, Elefanty AG, Brysha M, Willson TA, Nicola NA, Hilton DJ, and Alexander WS. Liver degeneration and lymphoid deficiencies in mice lacking suppressor of cytokine signaling-1. Proc Natl Acad Sci USA 95: 14395-14399, 1998.
32. Suzuki A, Hanada T, Mitsuyama K, Yoshida T, Kamizono S, Hoshino T, Kubo M, Yamashita A, Okabe M, Takeda K, Akira S, Matsumoto S, Toyonaga A, Sata M, and Yoshimura A. Cis3/socs3/ssi3 plays a negative regulatory role in stat3 activation and intestinal inflammation. J Exp Med 193: 471-482, 2001.
33. Teglund S, McKay C, Schuetz E, van Deursen JM, Stravopodis D, Wang D, Brown M, Bodner S, Grosveld G, and Ihle JN. Stat5a and Stat5b proteins have essential and nonessential, or redundant, roles in cytokine responses. Cell 93: 841-850, 1998.
34. Thissen JP and Verniers J. Inhibition by interleukin-1 beta and tumor necrosis factor-alpha of the insulin-like growth factor I messenger ribonucleic acid response to growth hormone in rat hepatocyte primary culture. Endocrinology 138: 1078-1084, 1997.
35. Verdier F, Rabionet R, Gouilleux F, Beisenherz-Huss C, Varlet P, Muller O, Mayeux P, Lacombe C, Gisselbrecht S, and Chretien S. A sequence of the CIS gene promoter interacts preferentially with two associated STAT5A dimers: a distinct biochemical difference between STAT5A and STAT5B. Mol Cell Biol 18: 5852-5860, 1998.
36. Wang P, Li N, and Li JS. Mechanism of growth hormone insensitivity induced by endotoxin. Acta Pharmacol Sin 23: 16-22, 2002.
37. Wolf M, Bohm S, Brand M, and Kreymann G. Proinflammatory cytokines interleukin 1 beta and tumor necrosis factor alpha inhibit growth hormone stimulation of insulin-like growth factor I synthesis and growth hormone receptor mRNA levels in cultured rat liver cells. Eur J Endocrinol 135: 729-737, 1996.
38. Zhang Y, Guan R, Jiang J, Kopchick JJ, Black RA, Baumann G, and Frank SJ. Growth hormone (GH)-induced dimerization inhibits phorbol ester-stimulated GH receptor proteolysis. J Biol Chem 276: 24565-24573, 2001.